These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 13539308)

  • 1. Antigenic variants of influenza A virus (PR8 strain) III. Serological relationships of a line of variants derived in sequence in mice given homologous vaccine.
    HAMRE D; LOOSLI CG; GERBER P
    J Exp Med; 1958 Jun; 107(6):829-44. PubMed ID: 13539308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic variants of influenza A virus (PR8 strain). II. Serological and immunological characteristics of variants derived from variants.
    GERBER P; HAMRE D; LOOSLI CG
    J Exp Med; 1956 Apr; 103(4):413-24. PubMed ID: 13306851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic variants of influenza A virus (PR8 strain). IV. Serological characteristics of a second line of variants developed in mice given polyvalent vaccine.
    HAMRE D; LOOSLI CG; GERBER P
    J Exp Med; 1958 Jun; 107(6):845-55. PubMed ID: 13539309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic variants of influenza A virus, PR8 strain. I. Their development during serial passage in the lungs of partially immune mice.
    GERBER P; LOOSLI CG; HAMBRE D
    J Exp Med; 1955 Jun; 101(6):627-38. PubMed ID: 14367684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic variants of influenza A virus (PR8 strain). V. Virulence, antigenic potency, and cross-protection tests in mice of the original and second series.
    LOOSLI CG; HAMRE D; GERBER P
    J Exp Med; 1958 Jun; 107(6):857-68. PubMed ID: 13539310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic variants of influenza A virus (PR8 strain). VI. Results of repeated passages of the same variant in mice immunized with monovalent homologous vaccine or polyvalent vaccine.
    HAMRE D; LOOSLI CG; EWERT RC
    J Infect Dis; 1961; 108():151-62. PubMed ID: 13711138
    [No Abstract]   [Full Text] [Related]  

  • 7. Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum.
    ARCHETTI I; HORSFALL FL
    J Exp Med; 1950 Nov; 92(5):441-62. PubMed ID: 14778924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain.
    Naito T; Mori K; Ushirogawa H; Takizawa N; Nobusawa E; Odagiri T; Tashiro M; Ohniwa RL; Nagata K; Saito M
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of influenza antibodies by serum absorption.
    JENSEN KE; DAVENPORT FM; HENNESSY AV; FRANCIS T
    J Exp Med; 1956 Aug; 104(2):199-209. PubMed ID: 13345965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine.
    DAVENPORT FM; HENNESSY AV
    J Exp Med; 1956 Jul; 104(1):85-97. PubMed ID: 13332182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain-specific elements in influenza antigens.
    HIRST GK
    J Exp Med; 1952 Dec; 96(6):589-603. PubMed ID: 13022853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
    Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
    J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of cross-reacting antibodies in creating resistance to influenza].
    Platonova AL
    Vopr Virusol; 1981; (6):709-12. PubMed ID: 6175111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza antibodies in the population of the USA; an epidemiological investigation.
    HILLEMAN MR; WERNER JH; GAULD RL
    Bull World Health Organ; 1953; 8(5-6):613-31. PubMed ID: 13094497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].
    Huang BY; Wang XP; Wang WL; Hu W; Gao Q; Tan WJ; Ruan L
    Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains.
    Kim JH; Liepkalns J; Reber AJ; Lu X; Music N; Jacob J; Sambhara S
    Vaccine; 2016 Jan; 34(4):495-502. PubMed ID: 26706277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
    Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic variants of influenza B virus.
    Schild GC; Pereira MS; Chakraverty P; Coleman MT; Dowdle WR; Chang WK
    Br Med J; 1973 Oct; 4(5885):127-31. PubMed ID: 4201694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
    PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.